Opthea decided to advance OPT-302 through Phase 3 by itself.Was...

First 130 Last

Share
Profile

Follow
Innameonly

78 Posts.

68

26/04/24

15:22

Post #: 73526859
Share

Originally posted by hottod: ↑

I am a long term holder in Opthea and here’s the story through my eyes.

Opthea announced outstanding Phase 2b trial results for OPT-302 in wet AMD in late 2019. This was a solid trial – a randomized, double-masked, sham-controlled clinical trial in 366 patients over 6 months of treatment.

In response, the share price rose to as high as ~ $4 (~A$635m market cap), up from ~ $0.65.

Opthea decided to advance OPT-302 through Phase 3 by itself.

Prior to commencing Phase 3 one year later, Opthea raised A$165m cash via a dual listing in the US. At the time, the Company projected Phase 3 trial results would be ready by H1 2023.
Following that raise, the share price had halved to ~A$2.

In August 2022, with its two Phase 3 trials still underway and cash reserves depleted, Opthea struck a financing deal with Launch Tx (Abingworth Carlyle) for up to A$260m along with a private placement for an extra A$128m.

The Launch Tx deal provided validation for Opthea’s OPT-302 clinical program. OPT was the first company chosen for financing by Launch Tx and the due diligence was exhaustive.
Deal details can be found here
https://hotcopper.com.au/threads/ann-form-6-k-with-sec.6893725/?post_id=63114958

Twelve months later, Opthea conducted a further cap raise for A$74m.

Opthea has now accessed all available funding from the Launch Tx deal but, having already raised A$627m to fund Phase 3, still has insufficient funding to take OPT-302 through to registration.

The share price fell to as low as A$0.33 last October and is now ~ A$0.64, which is where it was prior to Phase 2 success.

The further financing/cap raise that will be required will take the share price down again and even if there is success in Phase 3, I’m not sure that the share price will exceed the ~A$4 it reached following Phase 2. If it does, OPT’s market cap will be A$2.6bn +. And Opthea will owe Abingworth A$1bn+.

In summary, even if Phase 3 success (results are now anticipated in mid- 2025) were to drive the OPT market cap of Opthea to 6x what it is now, the share price would simply be back to where it was in 2019, post-Phase 2.

While there are obviously many key differences between the two companies, hanging on to OPT shares following Phase 2 success certainly hasn’t been rewarding.

Expand

Opthea decided to advance OPT-302 through Phase 3 by itself.

Was there a great debate about this decision among investors at the time, or did they just put faith in the company's management?

NEU Price at posting: $18.61 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

There are more pages in this discussion • 65 more messages in this thread...

First 130 Last

Add NEU (ASX) to my watchlist

(20min delay)
Last $19.82		Change 0.120(0.61%)		Mkt cap ! $2.530B

Open	High	Low	Value	Volume
$19.80	$19.82	$18.85	$6.333M	324.6K

Buyers (Bids)

No.	Vol.	Price($)
1	30	$19.70

Sellers (Offers)

Price($)	Vol.	No.
$19.83	1160	2

View Market Depth

No.	Vol.	Price($)
1	30	19.700
2	1160	19.640
1	846	19.630
1	2648	19.620
1	846	19.600

Price($)	Vol.	No.
19.830	1160	2
19.840	846	1
19.850	695	1
19.870	846	1
19.900	3846	2

Last trade - 16.10pm 06/05/2024 (20 minute delay)


Last $19.74		Change 0.120 ( 0.07 %)
Open	High	Low	Volume
$19.76	$19.80	$18.86	101075
Last updated 15.59pm 06/05/2024 ?

NEU (ASX) Chart

Opthea decided to advance OPT-302 through Phase 3 by itself.Was...

Featured News

Westpac tracks lower in profits in first half of 2024, with a 16% yoy drop amid slowing economy

Tamboran is listing on the NYSE, and Wall Street is paying attention

Sold out signs go up for RIU Resources Roundup in Sydney

Mantle Minerals to kick off drilling at Mt Berghaus in WA

Maiden drilling at West Arunta hints at major IOCG system for Rincon

Buyers (Bids)

Sellers (Offers)

Featured News

Opthea decided to advance OPT-302 through Phase 3 by itself.Was...

Featured News

Top Stories

Westpac tracks lower in profits in first half of 2024, with a 16% yoy drop amid slowing economy

Tamboran is listing on the NYSE, and Wall Street is paying attention

Sold out signs go up for RIU Resources Roundup in Sydney

Mantle Minerals to kick off drilling at Mt Berghaus in WA

Maiden drilling at West Arunta hints at major IOCG system for Rincon

Buyers (Bids)

Sellers (Offers)

Featured News